HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis.

Abstract
Nasal obstruction is a leading symptom in patients with allergic rhinitis and depends on inflammation characterized by Th2 polarization. Thus, IFN-gamma is typically deficient in allergic patients. It has been previously reported that ebastine is able to reduce Th2-dependent cytokines. The aim of this study is to preliminarily evaluate IFN-gamma production by peripheral blood mononuclear cells (PBMNC) and clinical changes after a treatment with lyophilized ebastine in patients with persistent allergic rhinitis (PER). Ten patients with PER were evaluated, 7 males and 3 females (mean age 32.4 +/- 6.2 years), all of whom received lyophilized ebastine (20 mg/daily) for 3 weeks. Total nasal symptom score (TSS), subjective evaluation score by visual analogue scale (VAS), and rhinomanometry were evaluated in all subjects before and after treatment. IFN-gamma production by peripheral blood mononuclear cells (PBMNC) was evaluated using different stimuli, in un-treated and ebastine-treated allergic patients by ELISPOT. Ebastine treatment induced significant increase of IFN-gamma production stimulated by grasses (p<0.0001) and Dermatophagoides farinae (p=0.0015). This effect was significantly related with TSS and VAS improvement after treatment (p=0.0038 and 0.004 respectively). In conclusion, this preliminary study demonstrates the effectiveness of ebastine treatment in increasing IFN-gamma production. The clinical relevance of this study is that the clinical improvement is related to the immunologic activity.
AuthorsG Ciprandi, I Cirillo, A Pistorio, M Di Gioacchino, D Fenoglio
JournalJournal of biological regulators and homeostatic agents (J Biol Regul Homeost Agents) 2009 Jan-Mar Vol. 23 Issue 1 Pg. 31-6 ISSN: 0393-974X [Print] Italy
PMID19321044 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Butyrophenones
  • Histamine H1 Antagonists
  • Piperidines
  • Interferon-gamma
  • ebastine
Topics
  • Adult
  • Butyrophenones (therapeutic use)
  • Female
  • Histamine H1 Antagonists (therapeutic use)
  • Humans
  • Interferon-gamma (biosynthesis)
  • Male
  • Piperidines (therapeutic use)
  • Rhinitis, Allergic, Perennial (drug therapy, immunology)
  • Rhinomanometry

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: